FindTrial
Sign In

Survival prediction model for metastatic renal cell carcinoma: A retrospective cohort study

Survival prediction model for metastatic renal cell carcinoma: A retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037816
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-09-02
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cell carcinoma

Interventions

renal&#32
cell&#32
carcinoma
Gold Standard:Clinical outcome
Index test:Survival&#32
prediction&#32
model&#32
for&#32
metastatic&#32

Sponsors

Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: Clinical data of renal cell carcinoma patients from 2010 to 2015.

Exclusion criteria

Exclusion criteria: a) bilateral renal masses; b) histological type, not clear renal cell carcinomas, papillary carcinomas, chromophobe carcinomas, collecting duct carcinoma and undifferentiated renal carcinoma; c) the operation method not non-surgery (code 00), partial nephrectomy (PN, code 30), and nephrectomy (code 40-50); d) unknown cause of death.

Design outcomes

Primary

MeasureTime frame
overall survival;C-indexs;—

Countries

China

Contacts

Public ContactXiaomin Sun

Southern Medical University

sunxiaomin198001@163.com+86 13710858369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026